GENESIS LAB
Board
1 director, last change in 2024Director (not named in the articles)
appointed by deed of 04-01-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 28-05-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Artikel 18. Vertegenwoordiging varı de vennootschap Alle handelingen die de vennootschap verbinden, inbegrepen deze waaraan een openbaar of…”deed of 29-03-2018
Mandates through the years
4 names, the dashed line is todayDirector (not named in the articles)
Manager
Statutory manager
Manager
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
-
- Manager, appointed by deed of 30-01-2018, until 04-01-2024
- Director (not named in the articles), appointed by deed of 04-01-2024, still in office
-
- Manager, appointed by deed of 30-01-2018, until 04-05-2021
- Manager, appointed by deed of 29-03-2018, no longer listed in the 2025 annual accounts
-
- Statutory manager, until 29-03-2018
-
- Manager, until 30-01-2018
- Manager, until 29-03-2018
Control
Shareholders
,
This company
GENESIS LAB
Equity -€20,991
Profit €9,979 in 2025
Capital
- Contribution
- €1
- Source
- 2025 annual accounts
Articles of association
deed of 04-01-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of March at 17:00
Shareholders
Stated in the deed
deed of 04-01-2024 ↗
- 749 shares
- 1 share
Stated in the deed
deed of 29-03-2018 ↗
- 749 shares
- 1 share
Capital transactions
Capital over time
- 04-01-2024 Converted to unavailable equity
- 04-01-2024 Converted to unavailable equity
- 29-03-2018 Capital stated in the deed · €18,592.01